---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-008901"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2023-07-06T23:59:59+00:00"
generated_at: "2026-06-13T11:58:04.709399+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences adjourns 2023 annual meeting to July 25 due to lack of quorum

## Summary
- Annual meeting convened and adjourned July 6, 2023 because required quorum was not present.
- Reconvened meeting scheduled for July 25, 2023 at 10:00 am ET via live webcast.
- Stockholders of record as of May 12, 2023 who have not yet voted are encouraged to vote by July 24.
- Proxies already submitted will be voted at the adjourned meeting unless properly revoked.
- No changes have been made to the proposals described in the May 24, 2023 proxy statement.

## SEC filing metadata
- accession: 0001654954-23-008901
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2023-07-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495423008901/0001654954-23-008901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495423008901/ndra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-008901
- JSON: https://secwatch.observer/filing/0001654954-23-008901.json
- Plain text: https://secwatch.observer/filing/0001654954-23-008901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.